Robert Alexander Ingram, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 69 shares at $7.00 ($483) on 2016-06-07, disclosed to the SEC on 2016-06-07.
Open-market sale of $483 CLSD by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |